TNFRSF8 and diffuse large B-cell lymphoma: In DLBCL cases with positive HCV NS3 expression (strong and weak positive), as many as 30 samples were known to express CD30, with a cut-off of >0% in 8 (26.7%) samples and a cut-off of >20% in 3 (10.0%). DLBCL patients with positive HCV NS3 expression more often showed positive CD30 expression as well, although this result was not significant (Table 5).